BJMO - volume 16, issue 3, may 2022
I.G.G.M. Biltjes MD, P. Bracke MD, N. van den Eede MD, D. Verhoeven MD, PhD, S. Haegeman MD, W. Volders MD
Artificial intelligence (AI) is being rapidly introduced in the daily practice of the medical professions. Here, an AI algorithm specialised in the detection of suspicious breast lesions on 2D and DBT images was used. This is a product from RMS: iCAD-ProFound 2D-3D Mammography. The first experiences are now presented, highlighting the advantages and pitfalls of the system.
(BELG J MED ONCOL 2022;16(3):114–8)
Read moreBJMO - volume 12, issue 7, november 2018
N. van den Eede MD, A. de Paepe MD, D. Strens MSc, P. Specenier MD, PhD
We calculated the management costs from diagnosis to death of glioblastoma patients treated at the Antwerp University Hospital between 2007 and 2016. Overall, the average cost per patient from the health care payer’s perspective was €45,165 (95% confidence interval €37,204–€54,104). The major cost driving factor was hospitalisation.
(BELG J MED ONCOL 2018;12(7):334–338)
Read moreBJMO - volume 12, issue 3, february 2018
N. van den Eede MD, P. Specenier MD, PhD, A. de Paepe MD
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
